Sven Lundstam

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Non-surgical management vs active treatment in T1a renal cell carcinoma: a population-based study.

Non-surgical management vs active treatment in T1a renal cell carcinoma: a population-based study.

Journal: BJU international

Published: November 13, 2025

Is Partial Nephrectomy A Primary Option for Patients with T1b Renal Cell Carcinoma-A National Population-Based Study.

Is Partial Nephrectomy A Primary Option for Patients with T1b Renal Cell Carcinoma-A National Population-Based Study.

Journal: Urology research & practice

Published: April 17, 2025

Healthcare costs in relation to increased use of preoperative renal tumour biopsies.

Healthcare costs in relation to increased use of preoperative renal tumour biopsies.

Journal: Scandinavian journal of urology

Published: October 27, 2024

Renal angiomyolipoma-investigating radiological signs indicative of risk for bleeding.

Renal angiomyolipoma-investigating radiological signs indicative of risk for bleeding.

Journal: Insights into imaging

Published: July 05, 2024

End-stage renal disease after renal cancer surgery: risk factors and overall survival.

End-stage renal disease after renal cancer surgery: risk factors and overall survival.

Journal: Scandinavian journal of urology

Published: March 08, 2024

Predictors for complication in renal cancer surgery: a national register study.

Predictors for complication in renal cancer surgery: a national register study.

Journal: Scandinavian journal of urology

Published: May 12, 2023

Long-term efficacy of selective arterial embolisation of renal angiomyolipoma.

Long-term efficacy of selective arterial embolisation of renal angiomyolipoma.

Journal: Scandinavian journal of urology

Published: April 12, 2023

Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study.

Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study.

Journal: JCO precision oncology

Published: February 27, 2023

Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma - results from the National Swedish Kidney Cancer Register.

Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma - results from the National Swedish Kidney Cancer Register.

Journal: Scandinavian journal of urology

Published: December 15, 2022

Noninvasive detection of any-stage cancer using free glycosaminoglycans.

Noninvasive detection of any-stage cancer using free glycosaminoglycans.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 05, 2022

Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma.

Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma.

Journal: Scandinavian journal of urology

Published: August 19, 2022

Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma-A Prospective Cohort Study.

Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma-A Prospective Cohort Study.

Journal: European urology open science

Published: June 09, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026